| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |